Farallon Capital Management LLC Ardelyx, Inc. Transaction History
Farallon Capital Management LLC
- $18.8 Billion
- Q4 2024
A detailed history of Farallon Capital Management LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 23,000 shares of ARDX stock, worth $124,890. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,000Holding current value
$124,890% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARDX
# of Institutions
232Shares Held
150MCall Options Held
1.54MPut Options Held
3.08M-
Janus Henderson Group PLC London, X024.4MShares$132 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$95.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.4MShares$78 Million0.0% of portfolio
-
State Street Corp Boston, MA11.6MShares$62.9 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C310.3MShares$56.2 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $840M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...